• Pharma
  • October 17, 2023
  • 40 views
Skin cancer drug Nidlegy shows positive results in Phase III trial

Italian-Swiss biotechnology company Philogen and Sun Pharmaceutical announced positive results from the Phase III “Pivotal” trial of Nidlegy on locally advanced melanoma. Nidlegy is Philogen’s prorpietary product to treat skin…